Description
Description: Sofocure tablets contain the active ingredient Sofosbuvir, available in a strength of 400 mg per tablet. Manufactured by Emcure Pharmaceuticals Ltd., Sofocure is used in the treatment of chronic hepatitis C virus (HCV) infection. Each pack of Sofocure contains 28 tablets and is intended for oral administration.
Medical Uses: Sofocure (Sofosbuvir) is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults. It is used in combination with other antiviral medications to inhibit the replication of the hepatitis C virus and help achieve sustained virologic response (SVR), which is considered a cure for HCV infection. Sofosbuvir belongs to a class of medications known as nucleotide polymerase inhibitors, which work by blocking the action of the hepatitis C virus RNA polymerase, an enzyme essential for viral replication.
Brand Name and International Trade Name: Sofocure is the brand name for Sofosbuvir manufactured by Emcure Pharmaceuticals Ltd. Internationally, Sofocure is known as Sovaldi.
Administration: Sofocure tablets are taken orally, typically once daily, with or without food, as directed by a healthcare professional. The dosage and duration of treatment may vary depending on factors such as the genotype of the hepatitis C virus, the patient’s liver function, and previous treatment history. Sofocure may be used in combination with other antiviral medications, such as ribavirin or ledipasvir, as part of a comprehensive treatment regimen for chronic hepatitis C infection.
Manufacturer: Sofocure tablets are manufactured by Emcure Pharmaceuticals Ltd., a leading pharmaceutical company known for its commitment to quality and innovation in healthcare. Emcure Pharmaceuticals Ltd. adheres to stringent manufacturing standards to ensure the safety, efficacy, and reliability of their products.
Storage: Sofocure tablets should be stored at room temperature (between 20°C and 25°C) in a dry place away from direct sunlight and moisture. It is essential to keep the medication out of reach of children and pets. Patients should not use Sofocure tablets beyond their expiration date.
Precautions:
- Sofocure should only be used under the supervision of a qualified healthcare professional experienced in the treatment of chronic hepatitis C infection.
- Patients should undergo regular monitoring of liver function tests and viral load during treatment with Sofocure.
- Sofosbuvir may interact with other medications, so patients should inform their healthcare provider about all current medications, including prescription drugs, over-the-counter medications, and supplements.
Side Effects: Common side effects of Sofocure may include:
- Fatigue
- Headache
- Nausea
- Insomnia
- Diarrhea
- Rash
Serious side effects such as liver toxicity and bradycardia may occur but are rare. Patients should seek medical attention if they experience any severe or persistent side effects while taking Sofocure.
Disclaimer: Sofocure tablets should only be used under the supervision of a qualified healthcare professional and as part of a comprehensive treatment plan for chronic hepatitis C virus infection. This description provides general information about the medication and its uses and should not replace medical advice from a healthcare provider.
Reviews
There are no reviews yet.